Antibiotic ear drops favored over popular oral antibiotics for ear infectionsDecember 13, 2006A multicenter study on treating common ear infections in children with ear tubes adds to a growing body of evidence that favors antibiotic ear drops over antibiotics swallowed in pill or liquid form in such cases, a UT Southwestern Medical Center researcher reports. The latest study, involving 80 children, showed that antibiotic ear drops performed better and faster in treating middle ear infections in children with ear tubes than merely taking oral antibiotics such as swallowing a pill or liquid. The findings are available online in the journal Pediatrics. "With the use of ear drops, you can put more potent medicine just where you need it," said Dr. Peter Roland, chairman of otolaryngology at UT Southwestern and one of the study's authors. The latest study looked at children ages 6 months to 12 years who had ear tubes, middle ear infections, and visible drainage in the ear. Both the oral and topical antibiotics cure the infections in more than 70 percent of cases. But the topical drops resolved the ear drainage three to five days faster and resulted in more clinical cures overall - 85 percent for those taking drops, compared to 59 percent for oral administration of medication - according to the study. That's in line with previous research and other findings that support increased use of topical antibiotics over oral antibiotics in other cases involving middle ear infections, one of the most common childhood afflictions, said Dr. Roland, who heads the Clinical Center for Auditory, Vestibular and Facial Nerve Disorders at UT Southwestern and who is also chief of pediatric otology at Children's Medical Center Dallas. Middle ear infections are the most common diagnosis for which children receive antibiotics, and insertion of ear tubes is the most common surgery performed on children. Many doctors treat these infections with oral antibiotics like amoxicillin, which is absorbed through the blood stream, said Dr. Roland. The tubes, researchers reported, provide better access to the middle ear, behind the ear drum, so more of the ear drops medicine reach the infection, avoiding potential intestinal and blood absorption that occurs with oral antibiotics. Researchers discovered that the concentration at the infection can be a thousandfold greater than when oral or IV medication is used. In addition, because the antibiotic is not distributed throughout the body, there is less chance of developing antibiotic resistance. Dr. Roland has previously demonstrated that middle ear infections are often caused by micro-organisms that are not susceptible to antibiotics approved for pediatric patients. But the ear infections are sensitive to topical ear drops. That research showed that children with ear tubes have different micro-organisms than those without the tubes, thereby requiring different treatment. Previous research has shown other advantages to topical antibiotics for middle-ear infections as well: - They tend to be more tolerable for children, so parents are more likely to comply with the whole regimen. - They tend to cause fewer gastrointestinal problems, such as diarrhea, gastroenteritis, dermatitis or complications from yeast infections than the oral antibiotics. - They lead to less antibiotic resistance, a major goal of the Centers for Disease Control and Prevention since 1995. UT Southwestern Medical Center |
|||||||||||||||||||||
| Related Oral Antibiotic Current Events and Oral Antibiotic News Articles Fewer deaths with preventive antibiotic use Administering antibiotics as a preventive measure to patients in intensive care units (ICUs) increases their chances of survival. This has emerged from a study involving nearly sixthousand Dutch patients in thirteen hospitals. Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), today announced positive results from Trial CL-05, the second of two pivotal phase III clinical trials designed to assess the safety and effectiveness of cethromycin, a novel once-a-day oral antibiotic for the treatment of mild-to-moderate community acquired pneumonia (CAP), the sixth leading cause of death in the United States. Study: Antibiotic gives hope to patients with IBS A new study found that patients reported greater global improvements in irritable bowel syndrome (IBS) symptoms and less bloating after taking rifaximin than patients taking placebo. Use of antibiotics for acne may increase risk of common infectious illness Individuals treated with antibiotics for acne for more than six weeks were more than twice as likely to develop an upper respiratory tract infection within one year as individuals with acne who were not treated with antibiotics. Oral amoxicillin could be future treatment for children with pneumonia in developing countries (pp 1104, 1141) Pneumonia-one of the world's deadliest diseases for young children in developing countries-could be treatable by the oral antibiotic amoxicillin rather than injectable penicillin, with implications for better health outcomes and reduced costs, conclude authors of an international study in this week's issue of THE LANCET. More Oral Antibiotic Current Events and Oral Antibiotic News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||